United States Cell Therapy Sales Market Report 2021

United States Cell Therapy Sales Market Report 2021

1 Cell Therapy Overview

1.1 Product Overview and Scope of Cell Therapy

1.2 Classification of Cell Therapy

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Cell Therapy

1.3.1 Skin disease

1.3.2 Cardiovascular

1.3.3 Central nervous system

1.3.4 Oncology

1.3.5 Diabetes

1.4 USA Market Size (Value and Volume) of Cell Therapy (2011-2021)

1.4.1 USA Cell Therapy Sales, Revenue and Price (2011-2021)

1.4.2 USA Cell Therapy Sales and Growth Rate (2011-2021)

1.4.3 USA Cell Therapy Revenue and Growth Rate (2011-2021)

2 USA Cell Therapy Competition by Manufacturers

2.1 USA Cell Therapy Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Cell Therapy Revenue and Share by Manufactures (2015 and 2016)

3 USA Cell Therapy (Volume and Value) by Type

3.1 USA Cell Therapy Sales and Market Share by Type (2011-2021)

3.2 USA Cell Therapy Revenue and Market Share by Type (2011-2021)

4 USA Cell Therapy (Volume) by Application

5 USA Cell Therapy Manufacturers Analysis

5.1 Celgene Corporation (U.S.)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Cell Therapy Product Type and Technology

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Cell Therapy Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)

5.2 StemCells, Inc. (U.S.)

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharma & Healthcare Product Type and Technology

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pharma & Healthcare Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)

5.3 Corning Incorporated (U.S.)

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Corning Incorporated (U.S.) Product Type and Technology

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Corning Incorporated (U.S.) Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)

5.4 Organogenesis Inc. (U.S.)

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Product Type and Technology

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Organogenesis Inc. (U.S.) Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)

5.5 Acelity (KCI Licensing) (U.S.)

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Acelity (KCI Licensing) (U.S.) Product Type and Technology

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Acelity (KCI Licensing) (U.S.) Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)

5.6 Vertex Pharmaceuticals Incorporated (U.S.)

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Vertex Pharmaceuticals Incorporated (U.S.) Product Type and Technology

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Vertex Pharmaceuticals Incorporated (U.S.) Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)

6 Cell Therapy Technology and Development Trend

6.1 Cell Therapy Technology Analysis

6.2 Cell Therapy Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Cell Therapy

Table Classification of Cell Therapy

Figure USA Sales Market Share of Cell Therapy by Type in 2015

Table Applications of Cell Therapy

Figure USA Sales Market Share of Cell Therapy by Application in 2015

Figure Skin disease Examples

Figure Cardiovascular Examples

Figure Central nervous system Examples

Figure Oncology Examples

Figure Diabetes Examples

Table USA Cell Therapy Sales, Revenue and Price (2011-2021)

Figure USA Cell Therapy Sales and Growth Rate (2011-2021)

Figure USA Cell Therapy Revenue and Growth Rate (2011-2021)

Table USA Cell Therapy Sales of Key Manufacturers (2015 and 2016)

Table USA Cell Therapy Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Cell Therapy Sales Share by Manufacturers

Figure 2016 Cell Therapy Sales Share by Manufacturers

Table USA Cell Therapy Revenue by Manufacturers (2015 and 2016)

Table USA Cell Therapy Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Cell Therapy Revenue Share by Manufacturers

Table 2016 USA Cell Therapy Revenue Share by Manufacturers

Table USA Cell Therapy Sales and Market Share by Type (2011-2021)

Table USA Cell Therapy Sales Share by Type (2011-2021)

Figure Sales Market Share of Cell Therapy by Type (2011-2021)

Figure USA Cell Therapy Sales Growth Rate by Type (2011-2021)

Table USA Cell Therapy Revenue and Market Share by Type (2011-2021)

Table USA Cell Therapy Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Cell Therapy by Type (2011-2021)

Figure USA Cell Therapy Revenue Growth Rate by Type (2011-2021)

Table USA Cell Therapy Sales and Market Share by Application (2011-2021)

Table USA Cell Therapy Sales Share by Application (2011-2021)

Figure Sales Market Share of Cell Therapy by Application (2011-2021)

Figure USA Cell Therapy Sales Growth Rate by Application (2011-2021)

Table Celgene Corporation (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of Celgene Corporation (U.S.) (2015 and 2016)

Table StemCells, Inc. (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of StemCells, Inc. (U.S.) (2015 and 2016)

Table Corning Incorporated (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of Corning Incorporated (U.S.) (2015 and 2016)

Table Organogenesis Inc. (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of Organogenesis Inc. (U.S.) (2015 and 2016)

Table Acelity (KCI Licensing) (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of Acelity (KCI Licensing) (U.S.) (2015 and 2016)

Table Vertex Pharmaceuticals Incorporated (U.S.) Basic Information List

Table Cell Therapy Sales, Revenue, Price of Vertex Pharmaceuticals Incorporated (U.S.) (2015 and 2016)